Victor Lewitzki

Universitätsklinikum Würzburg

Papers

1

Total Citations

152

H-Index

1

About

Victor Lewitzki is a leading radiation oncologist whose research focuses on stereotactic body radiotherapy (SBRT) for oligometastatic disease, with a particular emphasis on liver metastases. His major contribution lies in establishing large-scale, real-world evidence through the German Society for Radiation Oncology (DEGRO) SBRT database initiative. His most cited work, a pooled analysis of 474 patients with 623 liver metastases, is a landmark study that systematically analyzed patterns of care and outcomes, identifying key factors influencing treated metastasis control and overall survival. This work, with 152 citations, has helped define best practices for SBRT in the liver and has guided clinical decision-making for patients with limited metastatic spread. By leveraging multi-institutional data, Lewitzki has provided critical insights into the efficacy and safety of SBRT, moving the field beyond single-institution reports. His research is instrumental for students and clinicians seeking to understand the role of high-precision radiotherapy in the modern management of oligometastatic cancer, demonstrating how collaborative database initiatives can shape evidence-based radiation oncology.

Research Focus

Key Achievements

1
H-Index
1
Papers
152
Total Citations
152
Avg Citations/Paper
🏆 Most Cited Paper
The SBRT database initiative of the German Society for Radiation Oncology (DEGRO): patterns of care and outcome analysis of stereotactic body radiotherapy (SBRT) for liver oligometastases in 474 patients with 623 metastases
152 citations · 2018
📈 Most Prolific Year: 2018 (1 Papers)
🤝 Key Collaborators: 19
🏛 Institutions: Universitätsklinikum Würzburg

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago